1). Masatani T, Ito N, Shimizu K, Ito Y, Nakagawa K, Sawaki Y, et al. Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response. J Virol. 2010; 84:4002–12.
Article
2). Kuzmin IV, Hughes GJ, Rupprecht CE. Phylogenetic relationships of seven previously unclassified viruses within the family Rhabdoviridae using partial nucleoprotein gene sequences. J Gen Virol. 2006; 87:2323–31.
Article
3). Katayama S, Yamanaka M, Ota S, Shimizu Y. A New quantitative method for rabies virus by detection of nucleoprotein in virion using ELISA. J Vet Med Sci. 1999; 61:411–6.
Article
4). Yang DK, Kim HH, Lee KK, Yoo JY, Seomun H, Cho IS. Mass vaccination has led to the elimination of rabies since 2014 in South Korea. Clin Exp Vaccine Res. 2017; 6:111–9.
Article
5). Cheong Y, Kim B, Lee KJ, Park D, Kim S, Kim H, et al. Strategic model of national rabies control in Korea. Clin Exp Vaccine Res. 2014; 3:78–90.
Article
6). Sugiyama M, Yoshiki R, Tatsuno Y, Hiraga S, Itoh O, Gamoh K, et al. A new competitive enzyme-linked immunosorbent assay demonstrates adequate immune levels to rabies virus in compulsorily vaccinated Japanese domestic dogs. Clin Diagn Lab Immunol. 1997; 4:727–30.
Article
7). He Y, Gao D, Zhang M. Expression of the nucleoprotein gene of rabies virus for use as a diagnostic reagent. J Virol Methods. 2006; 138:147–51.
Article
8). Knoop EV, Freuling CM, Kliemt J, Selhorst T, Conraths FJ, Müller T. Evaluation of a commercial rabies ELISA as a replacement for serum neutralization assays as part of the pet travel scheme and oral vaccination campaigns of foxes. Berl Munch Tierarztl Wochenschr. 2010; 123:278–85.
9). Wasniewski M, Almeida I, Baur A, Bedekovic T, Boncea D, Chaves LB, et al. First international collaborative study to evaluate rabies antibody detection method for use in monitoring the effectiveness of oral vaccination programmes in fox and raccoon dog in Europe. J Virol Methods. 2016; 238:77–85.
Article
10). Franka R, Smith TG, Dyer JL, Wu X, Niezgoda M. Current and future tools for global canine rabies elimination. Antiviral Res. 2013; 100:220–5.
Article
11). Inoue S, Motoi Y, Kashimura T, Ono K, Yamada A. Safe and easy monitoring of anti-rabies antibody in dogs using his-tagged recombinant N-protein. Jpn J Infect Dis. 2003; 56:158–60.
12). Tursunov K, Begaliyeva A, Ingirbay B, Mukanov K, Ramanculov E, Shustov A, et al. Cloning and expression of fragment of the rabies virus nucleoprotein gene in Escherichia coli and evaluation of antigenicity of the expression product. Iran J Vet Res. 2017; 18:36–42.
13). Reid-Sanden FL, Sumner JW, Smith JS, Fekadu M, Shaddock JH, Bellini WJ. Rabies diagnostic reagents prepared from a rabies N gene recombinant expressed in baculovirus. J Clin Microbiol. 1990; 28:858–63.
Article
14). Kucinskaite I, Juozapaitis M, serva A, Zvirbliene A, Johnson N, Staniulis J, et al. Antigenic characterization of yeast-expressed lyssavirus nucleoproteins. Virus Genes. 2007; 35:521–9.
15). Perea Arango I, Loza Rubio E, Rojas Anaya E, Olivera Flores T, Gonzalez de la Vara L, Gómez Lim MA. Expression of the rabies virus nucleoprotein in plants at high levels and evaluation of immune responses in mice. Plant Cell Rep. 2008; 27:677–85.
16). Schrijver RS, Kramps JA. Critical factors affecting the diagnostic reliability of enzyme-linked immunosorbent assay formats. Rev Sci Tech. 1998; 17:550–61.
17). Zeng N, Gong M, Guo L, Qiu W, Li G. Development of SPA-ELISA for detection of antibodies against rabies virus based on expression of main antigenic determinant of nucleoprotein. Sheng Wu Gong Cheng Xue Bao. 2011; 27:1149–57.